Proprio is a Seattle-based surgical technology company that is pursuing the perfection of medical care by inventing new technologies that push the boundaries of what humans and computers can do together. Their proprietary platform combines light field technology, computer vision, data intelligence, and real-time anatomical alignment calculations to provide insightful, responsive information to surgeons, OR staff, and hospitals. Proprio aims to increase surgical accuracy, decrease complications and readmission rates, decrease revisions, decrease radiation exposure, decrease OR time, and decrease length of hospital stay.

Proprio

Proprio is a medical technology company based in Seattle, Washington. We create the new way of seeing™ in surgery through a proprietary platform of artificial intelligence, computer vision, and augmented/virtual reality. Our goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology. We work closely with industry-leading medical and technical advisors and reputable research institutions specializing in neurosurgery, medical devices, AI, computer vision, and robotics to dimensionalize and digitize surgical vision in groundbreaking, real-time applications. A quickly-growing, award-winning company, our team consists of creative, diverse, multi-disciplinary thinkers and innovators who value designing technology for positive and unprecedented social and industry impact.

Bold Capital Partners

Cota Capital

DCVC

Alan D. Frazier

Counterpart Advisors

Presence Capital

Acequia Capital (AceCap)

The Venture Reality Fund/VRF

Intel

Intel Capital

Proprio utilizes computer vision in its platform to help track and analyze complex patient anatomy. Utilizing Paradigm’s system, surgeons can access a more comprehensive view of the patient during surgery, all without the risk of excess radiation exposure. TechTarget News

https://lnkd.in/egrPCnGr 

#Innovation #Healthcare #AI #Spine #DigitalTwin #Surgery #ComputerVision

We’re thrilled to announce that Proprio has won the 2023 TITAN Innovation Award for Best Digital Health Technology Innovation!  Thank you to our amazing team for all the hard work and dedication that has made this achievement possible. 

We’re excited about what the future holds as we continue developing innovative medical technology that is poised to transform the future of surgery. 

https://bit.ly/3SJNh6E

 #AI #Healthcare #SpineTechnology #Startup #Medtech #Innovation

The healthcare industry is being transformed by the adoption of digital technology and the integration of artificial intelligence. The incorporation of emerging technologies has enabled the delivery of faster and more efficient patient care. 

More specifically, AI is now being used in surgery to improve patient outcomes, streamline processes, and enable more personalized care. Medical Economics 

https://lnkd.in/gaiAbp-u 

#Innovation #Healthcare #AI #Spine #Surgery #ComputerVision #MachineLearning

“The data collected across procedures could extend to a classification system and predictive tools that would allow similar patient case treatment patterns and outcomes to be understood more deeply for surgical training applications.” 

Tommy C., Proprio VP of Product Management & Marketing, was featured in Spinal News International. He explores the intricacies of spinal deformities and the potential to transform the surgical process by integrating personalized treatment plans with AI. 

https://lnkd.in/ePnqFGi9

#Healthcare #AI #SpineSurgery #MedTech #Lightfield

We are excited to announce that Proprio has been named a winner of the 2023 Best Technology in Spine award, presented by Orthopedics This Week! This award recognizes our co-founders and the entire Proprio team, who have been working hard to transform the future of spinal surgery. Thank you to Orthopedics This Week for this recognition! 

https://lnkd.in/dihapHgi

#AI #Healthcare #SpineTechnology #Medtech

"Using an array of sensors and cameras, Paradigm captures high-definition multimodal images during surgery and integrates them with preoperative scans to provide surgeons with real-time mapping of the anatomy."

Paradigm's first successful surgery was recently featured in ORTHOWORLD Inc. in an article that discusses how the device fuses light field images and AI to create a 3D image of the patient's anatomy.

https://lnkd.in/etTsnCyC

#Healthcare #AI #SpineSurgery #MedTech #Lightfield

Paradigm’s first in human surgery was showcased in Becker's Healthcare, highlighting the technology’s innovative use of light field technology to produce real-time, 3D renderings of the spine. 

“With the new technology, surgeons receive progress updates during the entirety of the surgery, providing live patient anatomy updates...Using sensors and cameras, Paradigm captures high-definition multimodal images during surgery and integrates them with preoperative scans to provide surgeons with real-time mapping.” 

https://lnkd.in/eUpudX4h

#Healthcare #AI #SpineSurgery #MedTech #Lightfield

We’re excited to announce the successful first-in-human use of our Paradigm system, in conjunction with Harborview Medical Center.

The case marks the first ever spine surgery utilizing light field technology. 

https://lnkd.in/ejwEZRgE

 #Healthcare #AI #Spine #Surgery #ComputerVision #MachineLearning #MedTech

The integration of AI into image-guided surgical tools enhances precision and can lead to improved patient outcomes. To sustain this progress, it is essential to encourage collaboration between surgeons, engineers, and technology experts. 

This is precisely why our team at Proprio is made up of a diverse team of experts from a variety of fields. This collaboration ensures that any new technology improves surgical pain points rather than adding to them. 

https://lnkd.in/ecEH8FTE 

#MedTech #Innovation #HealthcareInnovation #AI #SurgicalNavigation

COM:PROPRIOVISION

Proprio

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

monthly webtraffic

monthly webtraffic growth

stage

raised capital

Description

investor of

Metrics